Fractyl Health, Inc.
(NASDAQ: GUTS)
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
0.568 -
-1.262
(-68.96%)
Range
0.563 - 0.680
(20.78%)
Open
0.672
Previous Close
1.830
Bid Price
0.563
Bid Volume
1,200
Ask Price
0.568
Ask Volume
25
Volume
58,017,823
Value
23,532,833
Remark
-
Delayed prices. Updated at 29 Jan 2026 23:57.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
